Up-regulated expression of the β3 integrin and the 92-kDA gelatinase in human HT-144 melanoma cell tumors grown in nude mice

International Journal of Cancer

Volumn 68, Issue 5, 1996, Pages 650-662

  Gouon, Valérie ^a   Tucker, Gordon C ^b   Kraus Berthier, Laurence ^b   Atassi, Ghanem ^b   Kieffer, Nelly ^a,c  

^a Centre Universitaire   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; GELATINASE; INTEGRIN; MATRIGEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD; CELL DIVISION; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN BETA3; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; PLATELET MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; UP-REGULATION;

EID: 0029808419     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961127)68:5<650::AID-IJC16>3.0.CO;2-5     Document Type: Article

References (29)

1. ALBELDA, S.M., METTE, S.A., ELDER, D.E., STEWART, R., DAMJANOVICH, L., HERLYN, M. and BUCK, C.A., Integrin distribution in malignant melanoma: association of the β3 sub-unit with tumor progression. Cancer Res., 50, 6757-6764 (1990).
2. BOUKERCHE, H., BENCHAIBI, M., BERTHIER-VERGNES, O., LIZARD, G., BAILLY, M., BAILLY, M. and MCGREGOR, J.L., Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the β3-integrin sub-unit. Europ. J. Biochem., 220, 485-491 (1994).
3. DANEN, E.H.J., JANSEN, K.F.J., VAN KRAATS, A.A., CORNELISSEN, I.M.H.A., RUITER, D.J. and VAN MUIJEN, G.N.P., αv-integrins in human melanoma: gain of αvβ3 and loss of αvβ5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice. Int. J. Cancer, 61, 491-496 (1995).
4. DANEN, E.H.J., TEN BERGE, P.J.M., VAN MUIJEN, G.N.P., VAN'T HOF-GROOTENBOER, A.E., BRÖCKER, E.B. and RUITER, D.J., Emergence of α5β1 fibronectin- and αvβ3 vitronectin-receptor expression in melanocytic tumor progression. Histopathology, 24, 249-256 (1994).
5. DOCHERTY, A.J.P., O'CONNELL, J., CRABBE, J., ANGAL, S. and MURPHY, G., The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. TIBTech., 10, 200-207 (1992).
6. FELDING-HABERMANN, B., MUELLER, B.M., ROMERDAHL, C.A. and CHERESH, D.A., Involvement of integrin αv gene expression in human melanoma tumorigenicity. J. clin. Invest., 89, 2018-2022 (1992).
7. GEHLSEN, K.R., DAVIES, G.E. and SRIRAMARAO, P., Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin. exp. Metastasis, 10, 111-120 (1992).
8. GIANCOTTI, F.G. and RUOSLAHTI, E., Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell, 60, 849-859 (1990).
9. GUTMAN, M., SINGH, R.K., XIE, K., BUCANA, C.D. and FIDLER, I.J., Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res., 55, 2470-2475 (1995).
10. HIMELSTEIN, B.P., CANETE-SOLER, R., BERNHARD, E.J. and MUSCHEL, R.J., Induction of fibroblast 92-kDa-gelatinase/type-IV-collagenase expression by direct contact with metastatic tumor cells. J. Cell Sci., 107, 477-486 (1994).
11. HUHTALA, P., HUMPHRIES, M.J., MCCARTHY, J.B., TREMBLE, P.M., WERB, Z. and DAMSKY, C.H., Cooperative signaling by alpha-5-beta-1 and alpha-4-beta-1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol., 129, 867-879 (1995).
12. HUMPHRIES, M.J., OLDEN, K. and YAMADA, K., A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science, 233, 467-470 (1986).
13. HYNES, R.O., Integrins: versatility, modulation and signaling in cell adhesion. Cell, 69, 11-25 (1992).
14. JACOB, K., BOSSERHOFF, A.K., WACH, F., KNUCHEL, R., KLEIN, E.C., HEIN, R. and BUETTNER, R., Characterization of selected strongly and weakly invasive sub-lines of a primary human melanoma cell line and isolation of subtractive cDNA clones. Int. J. Cancer, 60, 668-675 (1995).
15. JULIANO, R.L. and VARNER, J.A., Adhesion molecules in cancer: the role of integrins. Curr. Opin. Cell Biol., 5, 812-818 (1993).
16. LENGYEL, E., GUM, R., JUAREZ, J., CLAYMAN, G., SEIKI, M., SATO, H. and BOYD, D., Induction of Mr-92,000-type-IV-collagenase expression in a squamous-cell carcinoma cell line by fibroblasts. Cancer Res., 55, 963-967 (1995).
17. LIOTTA, L.A. and STETLER-STEVENSON, W.G., Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res., 51, 5054-5059 (1991).
18. MCGREGOR, B.C., MCGREGOR, J.L., WEISS, L.W., WOOD, G.S., HU, C-H., BOUKERCHE, H. and WARNKE, R.A., Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Amer. J. clin. Path., 92, 495-499 (1989).
19. MIGNATTI, P., ROBBINS, E. and RIFKIN, D.B., Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47, 487-498 (1986).
20. MITJANS, F., SANDER, D., ADAM, J., SUTTER, A., MARTINEZ, J.M., JAGGLE, C.S., MOYANO, J.M., KREYSCH, H.G., PIULATS, J. and GOODMAN, S.L., An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J. Cell Sci., 108, 2825-2838 (1995).
21. MUELLER, B.M., YU, Y.B. and LAUG, W.E., Over-expression of plasminogen-activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc. nat. Acad. Sci. (Wash.), 92, 205-209 (1995).
22. NIP, J., RABBANI, S.A., SHIBATA, H.R. and BRODT, P., Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen-activator receptor in metastatic melanoma cells. J. clin. Invest., 95, 2096-2103 (1995).
23. NOËL, A.C., CALLÉ, A., EMONARD, H.P., NUSGENS, B.V., SIMAR, L., FOIDART, J., LAPIÈRE, C.M. and FOIDART, J-M., Invasion of reconstituted basement-membrane matrix is not correlated to the malignant metastatic cell phenotype. Cancer Res., 51, 405-414 (1991).
24. PLANTEFABER, L.C. and HYNES, R.O., Changes in integrin receptors on oncogenically transformed cells. Cell, 56, 281-290 (1989).
25. QIAN, F., VAUX, D.L. and WEISSMAN, I.L., Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell, 77, 335-347 (1994).
26. SEFTOR, R.E.B., SEFTOR, E.A., GEHLSEN, K.R., STETLER-STEVENSON, W.G., BROWN, P.D., RUOSLAHTI, E. and HENDRIX, M.J.C., Role of the αvβ3 integrin in human melanoma cell invasion. Proc. nat. Acad. Sci USA, 89, 1557-1561 (1992).
27. SHIH, I. and HERLYN, M., Autocrine and paracrine roles for growth factors in melanoma. In Vivo, 8, 113-124 (1994).
28. VEIGA, S.S., CHAMMAS, R., CELLA, N. and BRENTANI, R.R., Glycosylation of beta-1 integrins in B16-F10 mouse melanoma cells as determinant of differential binding and acquisition of biological activity. Int. J. Cancer, 61, 420-424 (1995).
29. ZAMBRUNO, G., MARCHISIO, P.C., MELCHIORI, A., BONDANZA, S., CANCEDDA, R. and DE LUCA, M., Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes. J. Cell Sci., 105, 179-185 (1993).